|
The buzz on transcatheter aortic valve replacement (TAVR) has long focused on its steady expansion to patients at progressively lower levels of surgical risk. But there are patients with aortic stenosis whose overall risk exceeds even the most severe that was addressed in the earliest major trials comparing TAVR with surgical aortic valve replacement.
|